Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GIANT: Bisoprolol in T2DM with Suboptimal BP Control
NCT01066039Phase 4Completed
- Sponsor
- Merck KGaA
- Start
- Apr 2010
- Primary completion
- Apr 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bisoprolol in hypertension (HTN), sponsored by Merck KGaA. Started Apr 2010; status: completed.
02
Drugs
bisoprolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01066039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01066039.